Sea snail chemical could be used as preventative treatment for bowel cancer, study shows

pharmafile | August 28, 2019 | News story | Research and Development Australia, Cancer, bowel cancer, pharma, research 

A chemical produced by Australian sea snails is showing promise as a potential treatment for cancer, according to researchers from Australia.

Researchers from Flinders University, Southern Cross University and Monash University in Australia, have found that a chemical compound found in the gland secretions of the Australian white rock sea snail (Dicathasis orbita) has anti-cancer properties.

The chemical, which is found in a purple fluid that is used by sea snails to protect their eggs, has in the past been found to have antibacterial and anti-inflammatory properties. Now, researchers have found the compound could be used as a preventative treatment for bowel cancer. Their findings were published in the journal Scientific Reports.

Professor Catherine Abbott from Flinders University explained: “After a decade of work, we have found an active compound derived from the substance produced by the mollusc’s gland which could be used as a preventative in bowel cancer. We’re very excited about these latest results and hope to attract investment from a pharma company to work on a new drug to reduce development of colorectal cancer tumours.”

Professor Benkendorff added: “In this latest research we have not only show that a specific snail compound can prevent the formation of tumors in a colon cancer model, but we were also able to use sophisticated technology to trace the metabolism of the compound inside the body. This is very important for drug development because it helps demonstrate the absence of potentially toxic side-effects.”

Louis Goss

Related Content

Geneos Therapeutics shares data from phase 1/2 trial for cancer vaccine

Geneos Therapeutics has announced that it has published positive safety, immunogenicity and efficacy data from …

Curve Therapeutics’ CSO publishes research on HIF inhibition for cancer treatment

Curve Therapeutics has announced that its chief scientific officer, Professor Ali Tavassoli has published research …

Bayer and Aignostics to collaborate for AI oncology research

Bayer and Aignostics have announced that they have entered into a strategic collaboration for several …

Latest content